Seroprevalence of toxoplasmosis, toxocariasis and cysticercosis in a rural settlement, São Paulo State, Brazil

References

• Rubinsky-Elefant G, Hirata CE, Yamamoto JH, Ferreira MU. Human toxocariasis: diagnosis, worldwide seroprevalences and clinical expression of the systemic and ocular forms. Ann Trop Med Parasitol. 2010;104(1):3–23.
   PubMed Web of Science ®Google Scholar
• Innes EA. A brief history and overview of Toxoplasma gondii. Zoonoses Public Health. 2010;57(1):1–7.
   PubMed Web of Science ®Google Scholar
• Carpio A. Neurocysticercosis: an update. Lancet Infect Dis.. 2002;2(12):751–62.
   PubMed Web of Science ®Google Scholar
• Nicoletti A, Bartoloni A, Reggio A, Bartalesi F, Roselli M, Sofia V, et al.. Epilepsy, cysticercosis, and toxocariasis: a population-based case–control study in rural Bolivia. Neurology. 2002;58(12):1256–61.
   PubMedGoogle Scholar
• Pereira-Chioccola VL, Vidal JE, Su C. Toxoplasma gondii infection and cerebral toxoplasmosis in HIV-infected patients. Future Microbiol. 2009;4(10):1363–79.
   PubMed Web of Science ®Google Scholar
• Agapejev S. Clinical and epidemiological aspects of neurocysticercosis in Brazil: a critical approach. Arq Neuropsiquiatr. 2003;61(3-B):822–8.
   PubMedGoogle Scholar
• Francisco FM, de Souza SL, Gennari SM, Pinheiro SR, Muradian V, Soares RM. Seroprevalence of toxoplasmosis in a low-income community in the São Paulo municipality, SP, Brazil. Rev Inst Med Trop São Paulo. 2006;48(3):167–70.
   PubMedGoogle Scholar
• Chieffi PP, Santos SV, Queiroz ML, Lescano SA. Human toxocariasis: contribution by Brazilian researchers. Rev Inst Med Trop São Paulo. 2009;51(6):301–8.
   PubMed Web of Science ®Google Scholar
• Elefant GR, Shimizu SH, Sanchez MC, Jacob CM, Ferreira AW. A serological follow-up of toxocariasis patients after chemotherapy based on the detection of IgG, IgA, and IgE antibodies by enzyme-linked immunosorbent assay. J Clin Lab Anal. 2006;20(4):164–72.
   PubMed Web of Science ®Google Scholar
• Peralta RH, Espíndola NM, Pardini AX, Iha AH, Moura H, Barr JR, et al.. Taenia crassiceps cysticerci: Characterization of the 14-kDa glycoprotein with homologies to antigens from Taenia solium cysticerci. Exp Parasitol. 2010;124(3):295–300.
   PubMed Web of Science ®Google Scholar
• Araújo PR, Ferreira AW. High diagnostic efficiency of IgM-ELISA with the use of multiple antigen peptides (MAP1) from T. gondii ESA (SAG-1, GRA-1 and GRA-7), in acute toxoplasmosis. Rev Inst Med Trop São Paulo. 2010;52(2):63–8.
   PubMed Web of Science ®Google Scholar
• Scheel CM, Khan A, Hancock K, Garcia HH, Gonzalez AE, Gilman RH, et al.. Cysticercosis Working Group in Peru. Serodiagnosis of neurocysticercosis using synthetic 8-kD proteins: comparison of assay formats. Am J Trop Med Hyg. 2005;73(4):771–6.
   PubMed Web of Science ®Google Scholar
• Espíndola NM, Iha AH, Fernandes I, Takayanagui OM, Machado LR, Livramento JA, et al.. Cysticercosis immunodiagnosis using 18- and 14-kilodalton proteins from Taenia crassiceps cysticercus antigens obtained by immunoaffinity chromatography. J Clin Microbiol. 2005;43(7):3178–84.
   PubMed Web of Science ®Google Scholar
• Prestes-Carneiro LE, Freitas SB, Zago SC, Miguel NA, Primo OB, Iha AH. et al. Taeniosis-cysticercosis complex in individuals of a peasants’ settlement (Teodoro Sampaio, Pontal of Paranapanema, SP, Brazil). Mem Inst Oswaldo Cruz. 2006;101(1):15–20.
   PubMed Web of Science ®Google Scholar
• Prestes-Carneiro LE, Santarém V, Zago SCS, Miguel NA, Zambelli Sde F, Villas R, et al.. Sero-epidemiology of toxocariasis in a rural settlement in São Paulo state, Brazil. Ann Trop Med Parasitol. 2008;102(4):347–56.
   PubMed Web of Science ®Google Scholar
• Prestes-Carneiro LE, Souza DH, Moreno GC, Troiani C, Santarém V, Zago SC, et al.. Toxocariasis/cysticercosis seroprevalence in a long-term rural settlement, São Paulo, Brazil. Parasitology. 2009;136(6):681–9.
   PubMed Web of Science ®Google Scholar
• Williams WJ, Beutler E, Erslev AJ, Lichtman AM. Hematology. New York: McGraw-Hill; 1991.
   Google Scholar
• de Savigny DH, Voller A, Woodruff AW. Toxocariasis: serological diagnosis by enzyme immunoassay. J Clin Pathol. 1979;32(2):284–8.
   PubMedGoogle Scholar
• Kanamura HY, Hoshino-Shimizu S, da Silva LC. Solubilization of antigens of S. mansoni adult worms for the passive hemagglutination test. Rev Inst Med Trop São Paulo. 1981;23(2):92–5.
   PubMedGoogle Scholar
• Araújo PR, Ferreira AW. Avidity of IgG antibodies against excreted/secreted antigens of Toxoplasma gondii: immunological marker for acute recent toxoplasmosis. Rev Soc Bras Med Trop. 2008;41(2):142–7.
   PubMed Web of Science ®Google Scholar
• Hughes HP, van Knapen F. Characterisation of a secretory antigen from Toxoplasma gondii and its role in circulating antigen production. Int J Parasitol. 1982;12(5):433–7.
   PubMed Web of Science ®Google Scholar
• Marcolino PT, Silva DA, Leser PG, Camargo ME, Mineo JR. Molecular markers in acute and chronic phases of human toxoplasmosis: determination of immunoglobulin G avidity by Western blotting. Clin Diagn Lab Immunol. 2000;7(3):384–9.
   PubMedGoogle Scholar
• Montoya JG, Liesenfeld O. Toxoplasmosis. Lancet. 2004;363(9425):1965–76.
   PubMed Web of Science ®Google Scholar
• Cavalcante GT, Aguilar DM, Camargo LM, Labruna MB, de Andrade HF, Meireles LR, et al.. Seroprevalence of Toxoplasma gondii antibodies in humans from rural Western Amazon, Brazil. J Parasitol. 2006;92(3):647–9.
   PubMed Web of Science ®Google Scholar
• Ferreira MU, Hiramoto RM, Aureliano DP, da Silva-Nunes M, da Silva NS, Malafronte RS, et al.. A community-based survey of human toxoplasmosis in rural Amazonia: seroprevalence, seroconversion rate, and associated risk factors. Am J Trop Med Hyg. 2009;81(1):171–6.
   PubMed Web of Science ®Google Scholar
• Torgerson PR, Rosenheim K, Tanner I, Ziadinov I, Grimm F, Brunner M, et al.. Echinococcosis, toxocarosis and toxoplasmosis screening in a rural community in eastern Kazakhstan. Trop Med Int Health. 2009;14(3):341–8.
   PubMed Web of Science ®Google Scholar
• Jones JL, Muccioli C, Belfort R, Holland GN, Roberts JM, Silveira C. Recently acquired Toxoplasma gondii infection, Brazil. Emerg Infect Dis. 2006;12(4):582–7.
   PubMed Web of Science ®Google Scholar
• Inagaki AD, Oliveira LA, Oliveira MF, Santos RC, Araújo RM, Alves JÁ, et al.. Seroprevalence of antibodies for toxoplasmosis, rubella, cytomegalovirus, syphilis and HIV among pregnant women in Sergipe. Rev Soc Bras Med Trop. 2009;42(5):532–36.
   PubMed Web of Science ®Google Scholar
• Vaz RS, Thomaz-Soccol V, Sumikawa E, Guimarães AT. Serological prevalence of Toxoplasma gondii antibodies in pregnant women from Southern Brazil. Parasitol Res. 2010;106(3):661–5.
   PubMed Web of Science ®Google Scholar
• Matowicka-Karna J, Dymicka-Piekarska V, Kemona H. Does Toxoplasma gondii infection affect the levels of IgE and cytokines (IL-5, IL-6, IL-10, IL-12, and TNF-alpha)? Clin Dev Immunol 2009. DOI: 10·1155/2009/374696
   Google Scholar
• Santarém VA, Franco Eda C, Kozuki FT, Fini D, Prestes-Carneiro LE. Environmental contamination by Toxocara spp. eggs in a rural settlement in Brazil. Rev Inst Med Trop São Paulo. 2008;50(5):279–81.
   PubMed Web of Science ®Google Scholar
• Safar EH, Abd-el Ghaffar FM, Saffar SA, Makled KM, Habib KS, el Abiad R. et al. Incidence of Toxoplasma and Toxocara antibodies among out-patients in the Ophthalmic Research Institute, Egypt. J Egypt Soc Parasitol. 1995;25(3):839–52.
   PubMedGoogle Scholar
• Azab ME, Safar EH, Khattab HM. Concomitant Toxoplasma and Toxocara infections. J Egypt Public Health Assoc. 1990;65(3–4):253–61.
   PubMedGoogle Scholar
• Fan CK, Liao CW, Cheng YC. Factors affecting disease manifestation of toxocarosis in humans: genetics and environment. Vet Parasitol. 2012; DOI: 10·1016/j.vetpar.2012·12·030.
   Web of Science ®Google Scholar